These effector-TH2 cells express higher level of IL4, IL5, and IL-9 compared with “classical” TH2 cells and thus could represent pathogenic cells mediating allergy through the IL-33–ST2 signaling pathway (28, 34). This evidence concerns the gene IL33 and allergic disease.